Soft tissue connects, surrounds, or supports internal organs and bones, and includes muscle, tendons, ligaments, fat, fibrous tissue, lymph & blood vessels, fasciae, and synovial membranes. Soft tissue allografts are substitute tissues used for reconstruction of deficient ligaments, torn menisci, spinal surgery, and osteochondral defects during knee surgery. Soft tissue is also used for wound care, dental surgery, aesthetics, etc. Increase in clinical application in medical procedures & sports injuries and rise in prevalence of degenerative joint diseases are projected to drive the global soft tissue market
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ :https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82408
Increase in Production of New Cellular, Tissue Allografts for Healing of Burns
Companies in the soft tissue market are bolstering their output capabilities in innovative cellular and tissue allografts to help surgeons heal their patients. AlloSourceยฎ – an allografts provider in the U.S. has announced that it is naming its new cellular and tissue allografts under the new brand AlloConnexโข.
Tendon and ligament transplantation is being carried out through skilled hands of surgeons. Manufacturers in the soft tissue market are building their portfolio in tendon and ligament allografts to support a multitude of procedures that surgeons perform to connect patients back to their active lifestyles. They are increasing the availability of single strand, double strand double bundle, and pre-shaped configurations in tendon and ligament allografts that help to heal severe burns.
The report concludes with the company profiles section that includes key information about the major players in the global soft tissue market
- Leading players analyzed in the report are
- Corneat Vision
- LinkoCare Life Sciences AB
- Presbia plc
- Bone Bank Allografts
- MTF Biologics
- CONMED Corporation
- AlloSource
- Arthrex, Inc.
- Zimmer Biomet Holdings, Inc.
- RTI Surgical, Inc.